Tag not found.

NUTRITION & CARE

Segment

Market-oriented Research & Development

The Nutrition & Care segment made considerable progress in extending its product portfolio in our growth fields. That included supplementing its in-house research competence through acquisitions and a new joint venture. The new expertise gained in this way should speed up market access.


  • By acquiring the probiotic business of the Spanish company NOREL, a leading supplier of probiotics, the Nutrition & Care segment has stepped up its research in this field. Probiotics are feed additives that facilitate largely antibiotic-free livestock farming and thus make a major contribution to healthy and sustainable nutrition. They are a key driver of the Sustainable Nutrition growth field.

  • The acquisition of the biotech company Transferra Nanosciences Inc. will drive forward development in the Healthcare Solutions growth field. Transferra has special expertise in liposomal drug delivery systems, paving the way for new developments based on our combined expertise.

  • R&D in the Advanced Food Ingredients growth field has been enhanced by acquiring MedPalett AS, a Norwegian producer of ingredients containing anthocyanins. Together with Evonik’s expertise in the production of delayed release systems, this opens the way for the development of new neutraceuticals geared to preventing cardiovascular disease.

  • The joint venture RSC Evonik Sweeteners Ltd., Bangkok (Thailand), which was established in 2015 by Evonik and a local sugar producer, opened a pilot plant for the production of isomalt at a site in Ban Pong in 2016. The low-cost production process developed by Evonik enables the Advanced Food Ingredients growth field to meet rising demand in Asia for reduced-sugar, low-calorie food.

More on Nutrition & Care

more